Liquidia Co. (NASDAQ:LQDA) Shares Purchased by Deutsche Bank AG

Deutsche Bank AG boosted its holdings in Liquidia Co. (NASDAQ:LQDA - Free Report) by 53.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 51,075 shares of the company's stock after buying an additional 17,790 shares during the period. Deutsche Bank AG owned 0.06% of Liquidia worth $601,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Steward Partners Investment Advisory LLC acquired a new position in shares of Liquidia during the 4th quarter valued at about $59,000. Summit Investment Advisors Inc. increased its position in Liquidia by 35.0% during the fourth quarter. Summit Investment Advisors Inc. now owns 6,632 shares of the company's stock worth $78,000 after purchasing an additional 1,719 shares during the last quarter. EntryPoint Capital LLC purchased a new position in Liquidia during the fourth quarter worth approximately $154,000. Bayesian Capital Management LP purchased a new position in Liquidia during the fourth quarter worth approximately $163,000. Finally, KLP Kapitalforvaltning AS acquired a new position in shares of Liquidia in the 4th quarter valued at $169,000. Hedge funds and other institutional investors own 64.54% of the company's stock.

Liquidia Trading Up 0.2%

NASDAQ:LQDA traded up $0.03 during mid-day trading on Friday, hitting $15.03. The company had a trading volume of 1,879,582 shares, compared to its average volume of 1,088,318. The business has a fifty day simple moving average of $14.71 and a 200-day simple moving average of $13.72. The firm has a market capitalization of $1.28 billion, a price-to-earnings ratio of -9.22 and a beta of 0.24. Liquidia Co. has a 1 year low of $8.26 and a 1 year high of $19.41.

Liquidia (NASDAQ:LQDA - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported ($0.45) EPS for the quarter, missing the consensus estimate of ($0.42) by ($0.03). The company had revenue of $3.12 million for the quarter, compared to analysts' expectations of $3.23 million. Liquidia had a negative net margin of 765.38% and a negative return on equity of 163.21%. As a group, research analysts anticipate that Liquidia Co. will post -1.51 earnings per share for the current year.

Analyst Upgrades and Downgrades

LQDA has been the subject of a number of research analyst reports. Oppenheimer set a $13.00 price objective on Liquidia and gave the stock an "underperform" rating in a report on Monday, May 19th. Wall Street Zen raised Liquidia from a "sell" rating to a "hold" rating in a research report on Thursday, May 22nd. Raymond James upped their price target on Liquidia from $27.00 to $29.00 and gave the stock a "strong-buy" rating in a research note on Friday, May 9th. BTIG Research restated a "buy" rating on shares of Liquidia in a report on Tuesday. Finally, Needham & Company LLC reiterated a "buy" rating and set a $25.00 target price on shares of Liquidia in a report on Wednesday. One research analyst has rated the stock with a sell rating, one has issued a hold rating, six have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, Liquidia has an average rating of "Moderate Buy" and a consensus price target of $26.67.

Insider Buying and Selling at Liquidia

In related news, CEO Roger Jeffs sold 14,130 shares of the firm's stock in a transaction on Monday, April 14th. The shares were sold at an average price of $13.57, for a total transaction of $191,744.10. Following the completion of the sale, the chief executive officer now directly owns 1,006,420 shares of the company's stock, valued at approximately $13,657,119.40. This trade represents a 1.38% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Jason Adair sold 1,856 shares of Liquidia stock in a transaction on Monday, April 14th. The stock was sold at an average price of $13.57, for a total transaction of $25,185.92. Following the sale, the insider now directly owns 184,304 shares in the company, valued at $2,501,005.28. This trade represents a 1.00% decrease in their position. The disclosure for this sale can be found here. Insiders sold 33,138 shares of company stock valued at $450,233 over the last 90 days. 26.50% of the stock is owned by corporate insiders.

About Liquidia

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).